Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

by Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K
Published 2017-10-01